- Direction
- Unknown
- Own history
- —
- Peers
- 14th
- Persistence
- TRANSIENT
· Wholesale-Drugs, Proprietaries & Druggists' Sundries
RESEARCH SNAPSHOTDataMeds AI, Inc.'s latest supported as-filed period reports revenue of $1.8M, 77.2% below the comparable as-filed period; gross margin moved 375 basis points higher on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 1787.00% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -162.61% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -77.15% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 84.84% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 10.24% · CORE
Level · gp.fundamentals.operating_margin
Raw value -412.68% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Operating income changed -33.5% from the comparable as-filed period.
Operating cash flow changed -39.2% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
MEDS · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001493152-26-048573SEC ↗8-KOct 20, 2026Period Oct 19, 20260001493152-26-047711SEC ↗8-KOct 16, 2026Period Oct 13, 20260001493152-26-047451SEC ↗8-KOct 13, 2026Period Oct 13, 20260001493152-26-046887SEC ↗8-KSep 17, 2026Period Sep 11, 20260001493152-26-043169SEC ↗8-KSep 16, 2026Period Sep 11, 20260001493152-26-042951SEC ↗8-KAug 18, 2026Period Aug 17, 20260001493152-26-038891SEC ↗10-QTransaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Level · gp.fundamentals.sbc_revenue_ratio
Raw value 67.69% · OPTIONAL
Operating margin changed -34208 basis points from the comparable as-filed period.
Cash & equivalents changed +484.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed -96.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross margin changed +375 basis points from the comparable as-filed period.
Revenue changed -77.2% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001493152-26-038581